| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| Pointshare Corporation |
| 1300 114th Avenue SE, Suite 100, Bellevue, WA 98004 * (425) 635-0500 |
| Business Description | The company is a leading provider of business-to-business services to local healthcare communities through our online network that connects physician practices with other healthcare participants. |
|
Filing Information IPO has been | |||
| To Trade As | PSHR (NASNTL) | Industry | Internet (SIC 7374) |
| Type of Stock Offered | Common Shares | Filing Date | 3/3/00 |
| Domestic Shares Filed | 0 | Filing Price | - - |
| Foreign Shares Filed | 0 | Offering Amount | $60,000,000 |
| Company Shares | 0 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| CS First Boston | Lead Manager | (212) 325-2000 |
| J.C. Bradford & Co. | Co-manager | (615) 748-9347 |
| Thomas Weisel Partners LLC | Co-manager | (415) 364-2500 |
| William Blair & Company | Co-manager | (312) 364-8990 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | - - Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/97 | 12/31/98 | 12/31/99 | ||||
| Revenues | - | - | 0.101 | 0.506 | 1.289 | - | - |
| Income from Oper. | - | - | -1.977 | -4.628 | -11.214 | - | - |
| Net Income | - | - | -1.913 | -4.629 | -11.072 | - | - |
| E.P.S | - | - | -1.320 | -9.690 | -9.750 | - | - |
| Revenue Growth (%) | - | - | 400.99 | 154.743 | - | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -7.51 | - | - | ||||
| Cash Flow - Inv. | -1.71 | - | - | ||||
| Cash Flow - Fin. | 44.22 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/99 | Financial Ratios | ||||
| Total Assets | 39.75 | Current Assets | 36.55 | Current Ratio | 14.46 |
| Total Liab. | 3.92 | Current Liab. | 2.53 | Debt Ratio | 9.86% |
| Total Equity | 35.83 | Working Cap. | 34.02 | Debt to Equity Ratio | 0.11 |
| Cash | 35.91 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for general corporate purposes including working capital and capital expenditures. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Venture Law Group |
| Bank's Law Firm | Shearman & Sterling |
| Registrar/Transfer Agent | ChaseMellon Shareholder Services, L.L.C. |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Morgenthaler Venture Partners IV | 14.30 | |
| ABS Capital Partners III, L.P. | 10.80 | |
| Seven Hills Partners, LLC | 8.00 | |
| Cardinal Health Partners, L.P. | 6.60 | |
| Utah Ventures II, L.P. | 6.10 | |
| Biotechnology Investments Limited | 5.70 | |
| Note: represents ownership of 5% or more prior to the offering. | ||